Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 1,119,852 |
|
|||||
| News | - | ||||||
| Day High | 1.16 | Low High |
|||||
| Day Low | 1.02 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Assertio Holdings Inc | ASRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.10 | 9.8% | 1.12 | 18:39:35 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.03 | 1.02 | 1.16 | 1.14 | 1.02 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,190 | 1,119,852 | $ 1.12 | $ 1,249,861 | - | 0.87 - 8.01 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:58:40 | 1 | $ 1.16 | USD |
Assertio Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 108.87M | 94.67M | - | 156.23M | 109.63M | 1.16 | 0.99 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Assertio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ASRT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.24 | 1.27 | 1.00 | 1.11 | 1,208,095 | -0.12 | -9.68% |
| 1 Month | 2.19 | 2.37 | 0.87 | 1.27 | 2,279,667 | -1.07 | -48.86% |
| 3 Months | 3.24 | 3.27 | 0.87 | 1.99 | 1,681,844 | -2.12 | -65.43% |
| 6 Months | 6.339 | 6.56 | 0.87 | 3.47 | 1,949,526 | -5.22 | -82.33% |
| 1 Year | 3.10 | 8.01 | 0.87 | 4.47 | 1,923,796 | -1.98 | -63.87% |
| 3 Years | 0.4213 | 8.01 | 0.331 | 1.83 | 2,984,494 | 0.6987 | 165.84% |
| 5 Years | 5.07 | 10.05 | 0.33 | 1.77 | 2,300,462 | -3.95 | -77.91% |
Assertio Description
| Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain. |
